Key result
Oral glucose tolerance testing detects impaired glucose tolerance in ~31% of non-diabetic hypertensive patients.
Why the study?
Hypertension combined with impaired glucose tolerance has an additive effect on the development of complications mediated by insulin resistance.
Cross-Sectional (n=120)
No
Warrants consideration of glucose tolerance screening in non-diabetic hypertensives; leaves open whether detection modifies vascular risk.
Introduction: Hypertension along with impaired glucose tolerance hasadditive effect on the development of complications. Insulin resistance mediates accelerateddevelopment of hypertension related complications. Study Design: Cross-sectional study.Setting: Outpatient department of Dow university hospital. Period: 1st March 2017 to 31st March2017. Method: OGTT was performed in 120 non-diabetic hypertensive patients presenting.Results: Among 120 patients, 77 were males whereas females were 43. Impaired glucosetolerance was found in 30.8 % patients. 40.5% were males and 59.4% were females. Conclusion:Impaired glucose tolerance can lead to future development of vascular complications inhypertensive patients due to lipogenic effects of insulin.
No takes yet. Share an insight, caveat, or question.
Mobin et al. (2017) conducted a cross-sectional in Hypertension (non-diabetic) (n=120). Oral Glucose Tolerance Test (OGTT) was evaluated on Impaired glucose tolerance prevalence. Among non-diabetic hypertensive patients, 30.8% were found to have impaired glucose tolerance upon screening with a 75g oral glucose tolerance test.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: